Michel Bouvier

E685771

Michel Bouvier is a biochemist and entrepreneur known for his pioneering work on G protein–coupled receptors (GPCRs) and for co-founding innovative drug discovery companies.

All labels observed (1)

Label Occurrences
Michel Bouvier canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf biochemist ⓘ
entrepreneur ⓘ
coFounds drug discovery companies ⓘ
fieldOfWork G protein–coupled receptors ⓘ
biochemistry ⓘ
pharmacology ⓘ
hasAcademicRole university professor ⓘ
hasActivity collaborating with pharmaceutical companies ⓘ
mentoring graduate students and postdoctoral fellows ⓘ
participating in scientific advisory boards ⓘ
publishing scientific articles on GPCRs ⓘ
hasContribution characterization of GPCR conformational dynamics ⓘ
development of biosensors to monitor GPCR activity ⓘ
elucidation of mechanisms underlying biased agonism ⓘ
pioneering work on GPCR signaling mechanisms ⓘ
translation of GPCR biology into drug discovery ⓘ
hasExpertise biosensor design ⓘ
molecular pharmacology ⓘ
protein engineering ⓘ
receptor pharmacology ⓘ
hasOccupation biotechnology entrepreneur ⓘ
university researcher ⓘ
hasRole company co‑founder ⓘ
researcher ⓘ
scientific advisor ⓘ
influences GPCR pharmacology field ⓘ
drug discovery strategies targeting GPCRs ⓘ
knownFor GPCR oligomerization ⓘ
allosteric modulation of GPCRs ⓘ
biased signaling at GPCRs ⓘ
research on G protein–coupled receptors ⓘ
use of BRET to study GPCRs ⓘ
language English ⓘ
French ⓘ
nationality Canadian ⓘ
notableFor bridging academic research and biotechnology entrepreneurship ⓘ
researchInterest cell signaling ⓘ
drug discovery ⓘ
pharmacological modulation of GPCRs ⓘ
protein–protein interactions in signaling ⓘ
receptor–effector coupling ⓘ
signal transduction ⓘ
sector biomedical research ⓘ
biotechnology industry ⓘ
worksOn novel pharmacological tools for GPCRs ⓘ
therapeutic targeting of GPCRs ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Heptares Therapeutics → foundedBy → Michel Bouvier ⓘ